Giuseppe Ciaramella sold $1.3M of Beam Therapeutics (BEAM)

Executed Oct 14 2024, disclosed Oct 16 2024, 2 days later.

Value, as filed

$1.3M

51,110 sh × $26.27

Executed

Oct 14 2024

the trade date, as filed

Disclosed

Oct 16 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Giuseppe Ciaramella President profile →

Giuseppe Ciaramella (President) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in Beam Therapeutics Inc. (BEAM). The largest single filing was $1.1M of BEAM (35,000 sh × $32.00, as filed), executed Feb 24.

The name

BEAM

Beam Therapeutics Inc. BEAM · Healthcare · 25 filings in 24 months ticker →

Healthcare · Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from seri…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Giuseppe Ciaramella in BEAM

BEAMSALE Beam Therapeutics Inc. $290K
11,810 sh × $24.58
Exec Apr 1
Filed Apr 6 · 5:30 PM ET † BEAMSALE Beam Therapeutics Inc. $1.1M
35,000 sh × $32.00
Exec Feb 24
Filed Feb 26 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. $136K
7,434 sh × $18.35
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. $1.3M
51,110 sh × $26.36
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET